Wednesday, 28 December 2016

Bioactive Ingredients Market Is Expected To Witness Growth At 7.5% CAGR In Asia Pacific From 2016 To 2024: Grand View Research, Inc.



The global bioactive ingredient market is expected to reach USD 51.71 billion by 2024, according to a new report by Grand View Research, Inc. Increasing disposable income coupled with growing health awareness among consumers is expected to aid the market growth. Their functional properties are capable of acting on the human metabolism physiology by providing potential health benefits.
The extraction of these bioactive compounds from original sources provides ample opportunities for adding value to food products and also improves the dietary patterns of the changed consumer’s lifestyle. They also help in preventing diseases related to heart, cancer, degenerative forms and Alzheimer’s.
Marine environment is a significant source for yielding bioactive components. Consumption of long-chain fatty acids by some fish species is strongly associated with protection from coronary heart diseases (CHD). Fish Origin Omega 3 PUFA oil are claimed to have a lot of health benefits related to a person’s diet.
Recently, it has been reported that there is an increasing demand for fish oils and fish oil fortified products across various regions. Marine organisms are potentially identified for calcium, antioxidants, anti-hypertensive proteins, selenium, and chitin. Their usage in functional food segment is regarded as the most important part and is expected to affect the overall market over the next eight years.
However, extraction of medicines derived from plants is affecting the environment by causing deforestation and is expected to affect the industry critically over the forecast period. Also, to meet the rising consumer's interest for these products, manufacturers is putting a lot of pressure on the marine organisms.
Recent technological advances such as microencapsulation are adopted for protecting bioactive ingredients from unwanted reactions and oxidation. There is a rising demand among manufacturers to find suitable solutions that provide higher productivity and adequate quality of the final products.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/bioactive-ingredients-market

Further key findings from the report suggest:
·         Fibers were the leading product segment and accounted for over 25% of global revenue in 2015. The effectiveness of fibers and rising awareness regarding its benefits are the primarily attributed reasons for this scenario.
·         Functional food & beverage product segment is expected to witness the highest CAGR of 7.4% over the forecast period. The consumers owing to its potential health benefits prefer this segment.
·         Asia Pacific was the leading consumer and accounted for over 35% of total revenue in 2015. The region is also expected to witness the highest growth of 7.5% over the next eight years. Changing lifestyle coupled with rising health consciousness among people particularly in China and India is drive the regional growth.
·         Key industry participants include Mazza Innovation Ltd., Sabinsa Corporation, Ingredion Incorporated, BASF, Cargill Inc, Ajinomoto Co. Inc, Archer Daniel Midland Company and DuPont.


Grand View Research has segmented the bioactive ingredient market on the basis of product, application and region:
Global Bioactive Ingredients Product Outlook (Revenue, USD Billion, 2014 - 2024)
·         Fiber
·         Vitamins
·         Omega 3 PUFA
·         Plant extracts
·         Minerals
·         Carotenoids & antioxidants
·         Probiotics
·         Other types
Global Bioactive Ingredients Application Outlook (Revenue, USD Billion, 2014 - 2024)
·         Functional food & beverages
·         Dietary supplements
·         Clinical Nutrition
·         Personal care
·         Other products
Global Bioactive Ingredients Regional Outlook (Revenue, USD Billion, 2014- 2024)
·         North America
o    U.S.
·         Europe
o    Germany
o    UK
o    France
·         Asia Pacific
o    China
o    India
·         Central & South America
·         Middle East & Africa

For press release of this report - http://www.grandviewresearch.com/press-release/global-bioactive-ingredients-market

Cardiovascular Devices Market To Reach USD 121 Billion By 2024, Will Witness Growth On Account Of Rising Demand In Healthcare Sector: Grand View Research, Inc.



Global cardiovascular devices market is anticipated to reach USD 121 billion by 2024, according to a new report by Grand View Research, Inc. Increasing geriatric population, sedentary life style coupled with unhealthy dietary habits is spurring the prevalence of cardiovascular diseases. Constant rise in the patients suffering from cardiovascular diseases and is expected to drive market growth during the forecast period.
Governments are trying to limit hospital readmissions to reduce the prevalence of hospital acquired infections (HAIs) by imposing penalties on hospitals. As a result, adoption of home healthcare, remote patient monitoring, and long term care services is rapidly increasing. Thus, demand for cardiovascular devices is increasing from hospitals, patients based in home settings, and long term care centers.
In addition, favorable government policies such as reimbursement coverage are fueling adoption of these devices. Thus, increasing target patient population, rising acceptance of home healthcare, and favorable government policies are some of the major factors driving the growth of the global cardiovascular devices market.
On the other hand, high device cost and stringent regulatory approval procedure are some of the prime factors challenging the growth of the market. In addition, lack of skilled professionals to perform surgical procedures using advanced devices is impeding the adoption of new devices.


Further key findings from the study suggest:
·         Availability of minimally invasive surgical devices coupled with high surgical cost is resulting in higher revenue share of surgical devices. As a result, surgical devices segment dominated the overall market in 2015.
·         Diagnostics and monitoring device segment is anticipated to grow at the fastest growth rate of 8.4% during the forecast period. Government initiatives to promote early diagnosis of the diseases, increasing adoption of home healthcare services and long term care centers is primarily affecting the growth of diagnostic and monitoring segment positively.
·         North America dominated with market share of 42.3% of the global market in 2015. Presence of large pool of target population, reimbursement coverage and high adoption rate for advanced treatments are some of the factors driving the growth of the cardiovascular devices market in North America.
·         Furthermore, favorable government policies and presence of well-defined regulatory framework are some of the factors augmenting the market growth in North America.
·         Asia Pacific is anticipated to register significant growth during the forecast period. Growth of the region would primarily attribute to anticipated rise in geriatric population prone to cardiac diseases and booming medical tourism in Asia Pacific.
·         Moreover, presence of rapidly developing countries such as India and China are expected to render positive growth to the Asia Pacific market. Government initiatives to improve healthcare infrastructure, increasing healthcare expenditure and increasing demand for advanced healthcare facilities are some of the factors anticipated to push the market in India and China towards swift growth.
·         Major players contributing to the global market include, Medtronic plc, Becton Dickinson and Company, Cardinal Health, Inc., Boston Scientific Corporation, B. Braun Melsungen AG and Abbott Laboratories, Inc., Cook Medical, Inc., Terumo Cardiovascular Systems Corporationand St. Jude Medical, Inc.
·         Competition among the key players would depend upon several factors included but not limited to manufacturing capacity, strong distribution network, pricing strategy and product innovation

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the cardiovascular devices market on the basis of product and region:
Cardiovascular Devices Market, by Product, 2013 - 2024 (USD Billion)
·         Diagnostic and monitoring devices          
o    ECG
o    Holter monitors
o    Event monitors
o    Cardiovascular diagnostic catheters
o    Implantable loop recorders
o    Echocardiogram
o    PET scan
o    MRI
o    Cardiac CT
o    Myocardial Perfusion Scans 
o    Doppler fetal monitor
o    Others
·         Surgical devices
o    Pacemakers
o    Stents
o    Catheters and accessories
o    Guidewires
o    Cannulae
o    Electrosurgical procedures
o    Valves
o    Occlusion devices
o    Others
Cardiovascular Devices, by Region, 2013 - 2024 (USD Billion)
·         North America
o    U.S. Cardiovascular Devices Market, by Product
o    Canada Cardiovascular Devices Market, by Product
·         Europe
o    Germany Cardiovascular Devices Market, by Product
o    U.K. Cardiovascular DevicesMarket, by Product
·         Asia Pacific
o    China Cardiovascular Devices Market, by Product
o    India Cardiovascular Devices Market, by Product
·         Latin America
o    Brazil Cardiovascular Devices Market, By Product
o    Mexico Cardiovascular Devices Market, By Product
·         MEA
o    South Africa Cardiovascular Devices Market, By Product

For press release of this report - http://www.grandviewresearch.com/press-release/global-cardiovascular-devices-market

Tuesday, 27 December 2016

Bioprosthetics Market To Exhibit Growth At 10.0% CAGR For Allograft Segment Till 2024: Grand View Research, Inc.



The global bioprosthetics market is expected to reach USD 6.41 billion by 2024, according to a new report by Grand View Research, Inc. The unprecedented upward shift in the lifestyle-associated habits leading to the high prevalence of cardiovascular diseases coupled with the increasing geriatric population base,which is highly susceptible to developing cardiac impairments and tissue damage,are presumed to impel the demand for the bioprosthetics market during the forecast period.
Lower biocompatibility, aesthetics, and strength exhibited by the synthetic material-based prosthetics indicate the indisputable requirement for incorporating bioprosthetics; consequentially, the increasing need for the tissue-engineered autologous, allogenic or xenograft products is anticipated to present the market with lucrative growth opportunities.
The growth in the demand for bioprostheses is attributed mainly to technological advancements comprising trans catheter valve fabrication technology, the construction of which involves a multidisciplinary approach, wherein wide-ranging technologies borrowed from varied devices including balloon angioplasty and coronary stents as well as medical disciplines, such as cardiac surgery and interventional cardiology, are merged to introduce a revolutionary quantum leap in the transcatheter valve replacement procedures. Moreover, a combination of the non-invasive imaging techniques, such as, echo cardiography angiography, MRI, and CT, are increasingly being employed, which allows the surgeons to visualize both the device and the anatomy of the patient thus eliminating the need to conduct an open heart surgery.


Further key findings from the study suggest:
·         The allograft segment is expected to exhibit growth at a significant CAGR of over 10.0% during the forecast period. This is a consequence of the following associated advantages such as reduced surgical time, smaller incisions, greater physiological acceptability, availability of larger grafts, and a safer alternative to procedures that employ synthetic grafts as they pose a high risk of complications under anesthesia
·         The plastic surgery and wound healing segment is anticipated to witness an exponential CAGR of over 11.0% in the application segment over the forecast period. This substantial share can be attributed to the increasing number of soft tissue repair procedures, such as in hernia and abdominal wall reconstruction
·          Additionally, as per a research published by the NCBI, the increase in case complexities drive the need to apply a multidisciplinary approach in performing the above-mentioned procedures, which augments the use of these bioprosthetics meshes to decrease the morbidity associated with chronic impairments
·         In 2015, Europe dominated the overall bioprosthetics market at over 40.0%. Moreover, the subsequent changes in the demographic trends, such as the frequent product approvals, increasing geriatric population base, lifestyle-associated changes, and the high awareness levels pertaining to the availability of bioprosthetics solutions are anticipated to drive the market growth in this region
·         For instance, In April 2016, St. Jude Medical, Inc. announced the European launch of Trifecta Surgical Valve to provide enhanced alternatives to patients requiring aortic valve replacements. This launch resulted in the expansion of the existing product portfolio of St. Jude Medical, Inc. in Europe
·         Some leading players in this industry include Edwards Lifesciences Corporation, St.Jude Medical, Inc., Sorin Group, CryoLife, Inc., Braile Biomedica, Inc., and Medtronic Plc; these players are increasingly involved in adopting collaborative strategies and launching frequent product approvals to facilitate business expansion
·         For instance, in March 2016, Edwards Lifesciences Corporation received an approval for the SAPIEN 3 Valve in Japan for the treatment of patients suffering from aortic stenosis. Additionally, the rising involvement of the players in this vertical toward developing and enhancing the supply of bioprosthetics through strategic alliances is likely to provide the market with a high potential growth platform in the future

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the bioprosthetics market on the basis of type, application,and region:
Global bioprosthetics type outlook (Revenue, USD Million, 2013 - 2024)
·         Allograft
·         Xenograft
o    Porcine
o    Bovine
Global bioprosthetics application outlook (Revenue, USD Million, 2013 - 2024)
·         Cardiovascular
·         Plastic surgery & wound healing
Bioprosthetics regional outlook (Revenue, USD Million, 2013 - 2024)
·         North America
·         U.S.
·         Canada
·         Europe
·         UK
·         Germany
·         Asia Pacific
·         Japan
·         China
·         India
·         Latin America
·         Mexico
·         Brazil
·         MEA
·         South Africa

For press release of this report - http://www.grandviewresearch.com/press-release/global-bioprosthetics-market